drugset / Trial / NCT02197637
Phase II Trial of Oral Vinorelbine in Children With Recurrent or Progressive Unresectable Low-Grade Glioma
Phase 2
Completed
39 enrolled
Centre Oscar Lambret
National Cancer Institute, France · collabPierre Fabre Laboratories · collab
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine whether oral vinorelbine is effective in the treatment of children with progressive or recurrent unresectable low grade glioma.
Timeline
- Start
- 2014-05
- Primary completion
- 2019-08
- Completion
- 2020-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Vinorelbine | Small molecule | 80 mg/m2 | Oral |